170257 ⎘
Assays involving biological materials from specific organisms or of a specific nature from viruses; RNA viruses Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
Sub-classes:SINGLE PARTICLE ANALYSIS METHOD FOR VIRAL NUCLEIC ACID VECTOR
#2HERV-K ANTIBODY THERAPEUTICS
#3ANTI-HERV-W ENVELOPE PROTEIN ANTIBODY FOR USE IN THE TREATMENT OF PSYCHOTIC DISEASES
#4Compositions and Methods for the Detection of Mycoplasma
#5METHODS AND KITS FOR QUANTIFYING THE REMOVAL OF MOCK VIRUS PARTICLES FROM A PURIFIED SOLUTION
#6METHOD FOR IDENTIFYING AND/OR REGULATING SENESCENCE
#7NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO
#8ENDOGENOUS RETROVIRUSES FOR THE DETECTION, DIAGNOSIS, AND PROGNOSIS OF CANCER
#9IDENTIFICATION AND APPLICATION OF ALV-J MHC-B2 RESTRICTIVE EPITOPE PEPTIDE
#10CELLULAR PLATFORM FOR RAPID AND COMPREHENSIVE T-CELL IMMUNOMONITORING
#11HERV INHIBITORS FOR USE IN TREATING TAUOPATHIES
#12BETARETROVIRUS EPITOPES AND RELATED METHODS OF USE
#13USE OF LIGANDS DERIVED FROM RECEPTOR-BINDING DOMAIN OF PORCINE ENDOGENOUS RETROVIRUS TYPE B FOR DIAGNOSING SMVT-RELATED DISEASES
#14STOCK SOLUTION OF RETROVIRUS LIKE PARTICLES WITH METHOD AND KIT
#15METHOD FOR ASSESSING SUSCEPTIBILITY OF A VIRUS TO TREATMENT BY MEASURING ENZYME ACTIVITY AND A SYSTEM THEREFORE
#16Detection device for bioluminescent detection of biomarkers from a biological fluid sample using luminescent sensing proteins
#17CAMPTOTHECIN DERIVATIVES AS ANTI-HIV AGENTS AND METHODS OF IDENTIFYING AGENTS THAT DISRUPT VIF SELF-ASSOCIATION
#18Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis
#19Assays for detecting analytes in samples and kits and compositions related thereto
#20Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles
#21Soluble and immunoreactive variants of HTLV capsid antigen P24
#22Methods and kits for quantifying the removal of mock virus particles from a purified solution
#23Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody
#24STOCK SOLUTION OF RETROVIRUS LIKE PARTICLES WITH METHOD AND KIT
#25Methods for the diagnosis of cancer through detection of human endogenous retrovirus WL (HERV-WL) envelope expression
#26Methods for evaluating viral clearance from a process solution employing mock viral particles
#27Soluble and immunoreactive variants of HTLV capsid antigen p24
#28CELLULAR PLATFORM FOR RAPID AND COMPREHENSIVE T-CELL IMMUNOMONITORING
#29Assays for detecting analytes in samples and kits and compositions related thereto
#30Camptothecin derivatives as anti-HIV agents and methods of identifying agents that disrupt Vif self-association
#31Method of determining virus removal from a sample containing a target protein using activated carbon
#32Methods for producing peptides including HERV-W envelope motifs and for producing antibodies specific for the peptides
#33METHODS AND KITS FOR THE DETECTION OF VIRAL INFECTIONS
#34ANTI-CANCER VACCINES
#35Trapping mammalian protein-protein complexes in virus-like particles utilizing HIV-1 GAG-bait fusion proteins
#36Highly immunogenic peptides derived from the human immunodeficiency virus V2 region
#37Methods for evaluating viral clearance from a biopharmaceutical solution employing mock viral particles
#38Method for monitoring HIV specific T cell responses
#39Inhibitors of viral integrase and methods of use
#40Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
#41Inhibitors of viral integrase and methods of use
#42Method for Determining the Cbl-b Expression
#43Method for the production and purification of bovine leukemia virus GP51 surface glycoprotein in the absence of bovine serum
#44ANTIBODIES FOR DIAGNOSIS AND THERAPEUTIC TREATMENT OF PROSTATE CANCER
#45NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO
#46DETECTION OF XENOTROPIC MURINE LEUKEMIA VIRUS
#47Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof
#48ENDOGENOUS RETROVIRUSES UP-REGULATED IN PROSTATE CANCER
#49Melanoma-Associated Endogenous Retrovirus (MERV) Derived Peptide Sequences And Their Therapeutic/Diagnostic Use
#50Methods for Detecting Metabolic States by Laser Ablation Electrospray Ionization Mass Spectrometry
#51SEROCONVERSION ASSAYS FOR DETECTING XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS
#52Endogenous retroviruses up-regulated in prostate cancer
#53Polynucleotide fragments of an infectious human endogenous retrovirus
#54Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor
#55Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use
#56Method for diagnosing and treatment of breast cancer and pharmaceuticals composition and kit for same
#57Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
#58Endogenous retrovirus polypeptides linked to oncogenic transformation
#59Novel retrovirus associated with myelodysplastic syndromes and uses thereof
#60Methods for diagnosing htlv-i-mediated diseases
#61Monitoring and treatment of amyotrophic lateral sclerosis
#62Compositions and methods for identifying antiviral agents
#63Method and device for detecting feline immunodeficiency virus
#64Diagnostic device using GP40
#65Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
#66Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens